what does this actually mean ? does it mean 43% of offshore expenditure associated with Phase 3 NanaBis trials will be cash rebated, in year of/after expenditure ? that would cover US and UK trails programs ? anyone get any ideas ?
Ann: Medlab Receives AusIndustry Overseas (R&D) Finding Approval, page-2
Add to My Watchlist
What is My Watchlist?